医院病例量对根治性肾切除加下腔静脉癌栓取出术结局的影响
基于美国国家癌症数据库分析2664例pT3b-c肾细胞癌行RN-IVCT患者,发现高病例量医院(年手术量>3例)患者中位总生存为60个月,显著优于中、低量医院(53和42个月,P=0.009),且多变量校正后高量医院全因死亡风险较低量医院降低24%(HR 0.76, 95%CI 0.65-0.89, P=0.001),短期死亡率无显著差异。
要点
- 高病例量医院(年RN-IVCT>3例)患者中位OS达60个月,低量医院为42个月。
- 多变量校正后高量医院较低量医院全因死亡风险降低24%(HR 0.76, 95%CI 0.65-0.89)。
- 医院病例量与30天和90天短期死亡率无显著差异。
核心结论
- 高医院病例量与RN-IVCT患者更长的总生存相关,支持对晚期肾细胞癌实施集中化诊疗。
研究设计与样本
- 回顾性队列研究,查询美国国家癌症数据库,纳入2664例接受RN-IVCT的pT3b-c肾细胞癌患者,覆盖573家医院。
- 医院按病例量百分位分为低量(<75百分位,年<0.67例)、中量(75-95百分位,年0.67-2.99例)、高量(>95百分位,年>3例),分别对应435、108、30家医院,覆盖28.5%、34.5%、37%的病例。
主要发现
- 低、中、高量医院患者的中位总生存分别为42、53、60个月(P=0.009)。
- 多变量校正后,高量医院较低量医院全因死亡风险降低24%(HR 0.76, 95%CI 0.65-0.89; P=0.001)。
- 按医院病例量分层,30天和90天短期死亡率无显著差异。
临床怎么用
- 对于接受RN-IVCT的晚期肾细胞癌患者,可优先考虑转诊至高病例量中心以改善长期生存。
- 临床决策中可将医院年RN-IVCT病例量(>3例/年)作为选择治疗机构的参考指标。
局限性
- 研究为回顾性数据库分析,可能存在选择偏倚和未测量混杂因素。
- 高病例量医院的定义基于病例量百分位,年手术量阈值较低(>3例/年)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Radical nephrectomy with inferior vena cava thrombectomy (RN-IVCT) is a complicated procedure for which the impact of hospital case volume on overall survival (OS) is unknown. OBJECTIVE: To assess the degree to which renal cell carcinoma (RCC) with inferior vena cava tumor thrombus (IVC-TT) care is centralized and to evaluate the impact of hospital case volume on outcomes following RN-IVCT. DESIGN, SETTING, AND PARTICIPANTS: The National Cancer Data Base was queried for patients with pT3b-c RCC treated with RN-IVCT. Hospitals were classified by case volume percentile as low (<75th percentile, <0.67 cases annually), intermediate (75th-95th percentile, 0.67-2.99 cases annually), or high (>95th percentile, >3 cases annually). OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: The primary outcome was OS. Secondary outcomes were short-term (30- and 90-d) mortality rates according to hospital case volume. Kaplan-Meier curves and Cox regression model were used to evaluate OS and the effect of covariables. RESULTS AND LIMITATIONS: There were 2664 cases of RN-IVCT for pT3b-c tumors reported by 573 institutions, of which 435, 108, and 30 were classified as low, intermediate, and high volume, accounting for 28.5%, 34.5%, and 37% of cases, respectively. Treatment at high-volume institutions was associated with better OS: the median OS was 42, 53, and 60 months for low, intermediate and high-volume centers, respectively (p=0.009). After multivariable adjustment, treatment at a high-volume institution was associated with a 24% relative risk reduction for all-cause mortality compared to treatment at a low-volume institution (hazard ratio 0.76, 95% confidence interval 0.65-0.89; p=0.001). There was no significant difference in short-term mortality following RN-IVCT when stratified by hospital case volume. CONCLUSIONS: Higher hospital case volume was associated with longer OS for patients undergoing RN-IVCT. These findings support efforts to centralize care for cases of advanced RCC. PATIENT SUMMARY: In this study we looked at the impact of hospital case volume on survival following surgery for renal cell carcinoma and inferior vena cava thrombectomy. Survival was significantly better in high-volume hospitals performing three or more procedures per year.
引用
- Freifeld Y, Woldu SL, Singla N, et al. Impact of Hospital Case Volume on Outcomes Following Radical Nephrectomy and Inferior Vena Cava Thrombectomy. Eur Urol Oncol. 2018. PMID: 31411983. doi:10.1016/j.euo.2018.10.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。